Across TCGA pan-cancer cohorts, DGKK RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated DGKK data layer compared with 10 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DGKK RNA is associated with better overall survival. In most high-consensus cancer types, elevated DGKK expression acts as an unfavorable survival marker, although some lineages such as KIRC and LGG show a favorable association.
KIRC, LGG, and OV are the cancer types where DGKK RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.